Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Results: Low sun exposure was associated with higher EDSS trajectories and lower serum 25(OH)D levels (p < 0.01).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Secondary analysis.

Secondary analysis

Analyses existing study data; this paper is not automatically another independent trial.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Methods: We performed a retrospective secondary analysis of a previously described longitudinal cohort of 132 patients with RRMS who were monitored over four years with serial assessments of EDSS, magnetic resonance imaging (MRI) inflammatory activity as gadolinium-enhancing lesions (GELs), new or enlarged T2-weighted lesions, serum 25(OH)D levels, and linear brain atrophy metrics.

Source: Abstract.

According to the original study protocol, patients were eligible for inclusion if they had a diagnosis of RRMS according to the 2010 or 2017 revised McDonald criteria, were aged >18 years, had an EDSS score ≤ 6.5, and had been receiving stable DMT for at least one year at baseline [].

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Smoking, Comorbidities, and Low Sun Exposure Are Associated with Clinical and Radiological Outcomes in Patients with Multiple Sclerosis: A Four-Year Observational Cohort Study

Secondary analysis · Journal of Clinical Medicine · 2026

Original publication title

Smoking, Comorbidities, and Low Sun Exposure Are Associated with Clinical and Radiological Outcomes in Patients with Multiple Sclerosis: A Four-Year Observational Cohort Study

Weronika Galus; Mateusz Winder; Aleksander Jerzy Owczarek; Katarzyna Zawiślak-Fornagiel; Magdalena Kiełbowicz-Hołysz; Joanna Siuda

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background:

While disease-modifying therapies reduce inflammatory activity in multiple sclerosis (MS), long-term disability progression remains insufficiently controlled. Increasing evidence points to modifiable environmental and lifestyle factors: such as smoking, sun exposure, comorbidities, and obesity: as contributors to neurodegeneration and progression independent of relapse activity.

Objective:

To evaluate the associations between smoking, comorbid conditions, sun exposure, and obesity on clinical and radiological progression in patients with relapsing: remitting MS (RRMS) over a 48-month observational period.

Methods:

We performed a retrospective secondary analysis of a previously described longitudinal cohort of 132 patients with RRMS who were monitored over four years with serial assessments of EDSS, magnetic resonance imaging (MRI) inflammatory activity as gadolinium-enhancing lesions (GELs), new or enlarged T2-weighted lesions, serum 25(OH)D levels, and linear brain atrophy metrics. Sun exposure, smoking status, obesity, and comorbidity burden were recorded at each time point.

Results:

Low sun exposure was associated with higher EDSS trajectories and lower serum 25(OH)D levels (p < 0.01). Smoking was associated with a higher probability of GELs (p < 0.05), while comorbidities were associated with relapse occurrence and GELs. Obesity was associated with vitamin D insufficiency but not clearly with clinical relapse activity, GELs, or EDSS trajectories. MRI-based indices confirmed increasing brain atrophy during follow-up, particularly in patients with multiple risk factors.

Conclusions:

Our findings suggest that selected modifiable lifestyle and clinical factors are associated with distinct clinical and radiological outcomes in RRMS. Integrating sun-safe outdoor activity, smoking cessation, comorbidity management, and weight control into MS care may support comprehensive risk management alongside pharmacological therapy.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To evaluate the associations between smoking, comorbid conditions, sun exposure, and obesity on clinical and radiological progression in patients with relapsing: remitting MS (RRMS) over a 48-month observational period.

Source: Objective:

Abstract: Results

Low sun exposure was associated with higher EDSS trajectories and lower serum 25(OH)D levels (p < 0.01). Smoking was associated with a higher probability of GELs (p < 0.05), while comorbidities were associated with relapse occurrence and GELs. Obesity was associated with vitamin D insufficiency but not clearly with clinical relapse activity, GELs, or EDSS trajectories. MRI-based indices confirmed increasing brain atrophy during follow-up, particularly in patients with multiple risk factors.

Source: Results:

Abstract: Conclusions

Our findings suggest that selected modifiable lifestyle and clinical factors are associated with distinct clinical and radiological outcomes in RRMS. Integrating sun-safe outdoor activity, smoking cessation, comorbidity management, and weight control into MS care may support comprehensive risk management alongside pharmacological therapy.

Source: Conclusions:
Authors’ abstract

Background:

While disease-modifying therapies reduce inflammatory activity in multiple sclerosis (MS), long-term disability progression remains insufficiently controlled. Increasing evidence points to modifiable environmental and lifestyle factors: such as smoking, sun exposure, comorbidities, and obesity: as contributors to neurodegeneration and progression independent of relapse activity.

Objective:

To evaluate the associations between smoking, comorbid conditions, sun exposure, and obesity on clinical and radiological progression in patients with relapsing: remitting MS (RRMS) over a 48-month observational period.

Methods:

We performed a retrospective secondary analysis of a previously described longitudinal cohort of 132 patients with RRMS who were monitored over four years with serial assessments of EDSS, magnetic resonance imaging (MRI) inflammatory activity as gadolinium-enhancing lesions (GELs), new or enlarged T2-weighted lesions, serum 25(OH)D levels, and linear brain atrophy metrics. Sun exposure, smoking status, obesity, and comorbidity burden were recorded at each time point.

Results:

Low sun exposure was associated with higher EDSS trajectories and lower serum 25(OH)D levels (p < 0.01). Smoking was associated with a higher probability of GELs (p < 0.05), while comorbidities were associated with relapse occurrence and GELs. Obesity was associated with vitamin D insufficiency but not clearly with clinical relapse activity, GELs, or EDSS trajectories. MRI-based indices confirmed increasing brain atrophy during follow-up, particularly in patients with multiple risk factors.

Conclusions:

Our findings suggest that selected modifiable lifestyle and clinical factors are associated with distinct clinical and radiological outcomes in RRMS. Integrating sun-safe outdoor activity, smoking cessation, comorbidity management, and weight control into MS care may support comprehensive risk management alongside pharmacological therapy.

Publication and source details

Original title: Smoking, Comorbidities, and Low Sun Exposure Are Associated with Clinical and Radiological Outcomes in Patients with Multiple Sclerosis: A Four-Year Observational Cohort Study

Weronika Galus; Mateusz Winder; Aleksander Jerzy Owczarek; Katarzyna Zawiślak-Fornagiel; Magdalena Kiełbowicz-Hołysz; Joanna Siuda

Journal of Clinical Medicine · 2026

* Correspondence: wgalus@sum.edu.pl; Tel.: +48-32-789-4601© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Medical University of Silesia from teaching and research subsidy fundshttps://ror.org/005k7hp45 This work was supported by the Medical University of Silesia from teaching and research subsidy funds.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:23:26.203542+00:00

DOI: 10.3390/jcm15114270 · PMC13257719